Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
about
Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@en
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@nl
type
label
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@en
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@nl
prefLabel
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@en
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@nl
P2093
P2860
P1476
Intravitreal bevacizumab for n ...... reated by proton beam therapy.
@en
P2093
Christine Levy
Laurence Desjardins
Livia Lumbroso-Le Rouic
Marie Najean
Nathalie Cassoux
Rémi Dendale
Stéphanie Lemaitre
Sylvain Dureau
P2860
P2888
P304
P356
10.1007/S00417-017-3834-3
P50
P577
2017-11-07T00:00:00Z